Life‐Threatening Prolonged ICANS Following Tarlatamab Treatment in Extensive‐Stage Small Cell Lung Cancer With Brain Metastases: A Case Report
ABSTRACT We report the case of a 75‐year‐old woman with extensive‐stage small cell lung cancer (ES‐SCLC) who developed severe, prolonged immune effector cell‐associated neurotoxicity syndrome (ICANS) following tarlatamab. She had previously received first‐line carboplatin, etoposide, and durvalumab,...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2026-05-01
|
| Serija: | Respirology Case Reports |
| Teme: | |
| Online pristup: | https://doi.org/10.1002/rcr2.70617 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|